Fact or Fiction, It Is Time for a Verdict on Vasculogenic Mimicry?

angiogenesis endothelial in vivo–in vitro model vasculogenic mimicry (VM)

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2019
Historique:
received: 26 04 2019
accepted: 10 07 2019
entrez: 21 8 2019
pubmed: 21 8 2019
medline: 21 8 2019
Statut: epublish

Résumé

The term vasculogenic mimicry (VM) refers to the capacity of certain cancer cells to form fluid-conducting structures within a tumor in an endothelial cell (EC)-free manner. Ever since its first report by Maniotis in 1999, the existence of VM has been an extremely contentious issue. The overwhelming consensus of the literature suggests that VM is frequently observed in highly aggressive tumors and correlates to lower patient survival. While the presence of VM

Identifiants

pubmed: 31428573
doi: 10.3389/fonc.2019.00680
pmc: PMC6688045
doi:

Types de publication

Journal Article

Langues

eng

Pagination

680

Références

Am J Pathol. 1999 Sep;155(3):675-9
pubmed: 10487823
Am J Pathol. 1999 Sep;155(3):739-52
pubmed: 10487832
Am J Pathol. 2000 Feb;156(2):359
pubmed: 10666363
Am J Pathol. 2000 Feb;156(2):383-8
pubmed: 10666365
Placenta. 2000 Sep;21(7):670-7
pubmed: 10985970
Am J Pathol. 2001 Apr;158(4):1279-88
pubmed: 11290546
Cancer Res. 2001 Apr 15;61(8):3250-5
pubmed: 11309274
Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):8018-23
pubmed: 11416160
Cancer Res. 2001 Sep 1;61(17):6322-7
pubmed: 11522618
Cancer Res. 2002 Jan 15;62(2):560-6
pubmed: 11809710
Prostate. 2002 Feb 15;50(3):189-201
pubmed: 11813211
Cancer Res. 2002 Feb 1;62(3):665-8
pubmed: 11830517
Cancer Res. 2002 Feb 1;62(3):860-6
pubmed: 11830544
Cell Signal. 2002 May;14(5):381-95
pubmed: 11882383
Clin Exp Metastasis. 2002;19(3):233-46
pubmed: 12067204
Lab Invest. 2002 Aug;82(8):1031-43
pubmed: 12177242
Cancer Res. 2002 Oct 1;62(19):5470-5
pubmed: 12359755
Mol Cancer Ther. 2002 Nov;1(13):1173-9
pubmed: 12479698
Microsc Res Tech. 2003 Jan 1;60(1):13-22
pubmed: 12500256
Cancer Biol Ther. 2002 Nov-Dec;1(6):661-4
pubmed: 12642690
Nat Rev Cancer. 2003 Jun;3(6):411-21
pubmed: 12778131
Cancer Immunol Immunother. 2003 Oct;52(10):643-7
pubmed: 12827304
Cancer Res. 2003 Aug 15;63(16):4757-62
pubmed: 12941789
Cancer Res. 2003 Sep 1;63(17):5381-9
pubmed: 14500372
Int J Oncol. 2004 Dec;25(6):1609-14
pubmed: 15547697
Dokl Biol Sci. 2005 May-Jun;402:217-20
pubmed: 16121949
Cancer Res. 2005 Nov 1;65(21):9851-60
pubmed: 16267008
Oncol Rep. 2006 Jan;15(1):15-20
pubmed: 16328029
J Microsc. 2006 Jan;221(Pt 1):30-45
pubmed: 16438687
Oncol Rep. 2006 Oct;16(4):693-8
pubmed: 16969481
Cancer Lett. 2007 May 8;249(2):188-97
pubmed: 16997457
Med Oncol. 2006;23(3):403-9
pubmed: 17018898
Stem Cells Dev. 2008 Feb;17(1):19-22
pubmed: 18205547
Hum Pathol. 2008 Mar;39(3):444-51
pubmed: 18261629
Biotechnol Bioeng. 2008 Oct 1;101(2):307-16
pubmed: 18454497
PLoS One. 2009;4(1):e4132
pubmed: 19125185
Cancer Res. 2009 Feb 1;69(3):802-9
pubmed: 19176384
Tissue Eng Part A. 2009 Sep;15(9):2643-51
pubmed: 19207042
Oncol Rep. 2009 Apr;21(4):989-94
pubmed: 19287998
Can J Urol. 2009 Aug;16(4):4726-32
pubmed: 19671223
Dis Colon Rectum. 2009 Dec;52(12):2028-35
pubmed: 19934926
Cancer Sci. 2010 Feb;101(2):293-9
pubmed: 19961486
Pathol Oncol Res. 2010 Jun;16(2):259-66
pubmed: 20016961
Med Oncol. 2011 Dec;28 Suppl 1:S228-38
pubmed: 20957524
J Exp Clin Cancer Res. 2011 Apr 29;30:46
pubmed: 21529356
Oncogene. 2011 Nov 3;30(44):4498-508
pubmed: 21602894
J Vis Exp. 2011 Sep 07;(55):null
pubmed: 21931289
Cancer Sci. 2012 Apr;103(4):813-20
pubmed: 22212097
Cancer Biol Ther. 2012 Mar;13(5):341-8
pubmed: 22258034
Oncol Rep. 2012 Jun;27(6):1990-2002
pubmed: 22470047
Clin Cancer Res. 2012 May 15;18(10):2726-32
pubmed: 22474319
Am J Pathol. 2012 Oct;181(4):1115-25
pubmed: 22944600
J Neurosci. 2012 Sep 12;32(37):12950-60
pubmed: 22973019
Int J Clin Exp Pathol. 2012;5(7):614-23
pubmed: 22977656
Exp Cell Res. 2013 May 15;319(9):1317-23
pubmed: 23291327
J Neurooncol. 2013 May;112(3):339-45
pubmed: 23417321
Int J Oncol. 2013 Jun;42(6):2103-15
pubmed: 23588386
J Huazhong Univ Sci Technolog Med Sci. 2013 Jun;33(3):385-391
pubmed: 23771665
J Cell Mol Med. 2013 Aug;17(8):1038-47
pubmed: 23815612
Angiogenesis. 2014 Jul;17(3):471-94
pubmed: 24482243
Gynecol Oncol. 2014 Mar;132(3):730-8
pubmed: 24503464
Cell Tissue Res. 2014 Mar;355(3):523-7
pubmed: 24619142
Oncol Lett. 2014 Jul;8(1):431-437
pubmed: 24959290
Hum Pathol. 2014 Oct;45(10):2120-9
pubmed: 25123071
Mol Cancer Ther. 2014 Dec;13(12):3107-22
pubmed: 25277383
Hum Pathol. 2015 Jan;46(1):120-8
pubmed: 25455996
J Biol Res (Thessalon). 2014 May 13;21(1):4
pubmed: 25984487
Int J Clin Exp Pathol. 2015 Apr 01;8(4):4033-43
pubmed: 26097591
Int J Mol Sci. 2015 Aug 10;16(8):18564-79
pubmed: 26266404
Oncol Lett. 2015 Sep;10(3):1635-1641
pubmed: 26622724
Melanoma Res. 2016 Apr;26(2):145-52
pubmed: 26636907
Int J Urol. 2016 May;23(5):371-7
pubmed: 26915598
Genet Mol Res. 2016 Mar 04;15(1):15017396
pubmed: 26985936
Biotech Histochem. 2016 Jul;91(5):309-26
pubmed: 27149658
Oncotarget. 2016 Jun 21;7(25):38467-86
pubmed: 27509260
Int J Mol Sci. 2016 Sep 06;17(9):
pubmed: 27608016
Nat Commun. 2016 Nov 09;7:13322
pubmed: 27827359
Sci Rep. 2016 Nov 11;6:36659
pubmed: 27834402
Oncol Res Treat. 2017;40(1-2):35-41
pubmed: 28118629
Diagn Pathol. 2017 Mar 2;12(1):23
pubmed: 28253891
Cancer Biol Ther. 2017 Apr 3;18(4):205-213
pubmed: 28278077
Mol Cancer. 2017 Mar 21;16(1):65
pubmed: 28320399
BMC Surg. 2017 Apr 21;17(1):47
pubmed: 28431527
Transl Oncol. 2017 Aug;10(4):650-660
pubmed: 28668763
J Cell Mol Med. 2017 Dec;21(12):3579-3591
pubmed: 28699701
Sci Rep. 2017 Aug 1;7(1):6985
pubmed: 28765613
Oncotarget. 2017 Apr 21;8(35):58163-58171
pubmed: 28938545
Oncol Lett. 2018 Apr;15(4):5193-5200
pubmed: 29552157
Oncogene. 2019 Jan;38(2):228-243
pubmed: 30087438
J Pathol. 2018 Dec;246(4):447-458
pubmed: 30101525
Pathol Oncol Res. 2019 Jul;25(3):849-858
pubmed: 30361906
J Cell Biochem. 2019 Aug;120(8):12473-12488
pubmed: 30825232
Gene. 2019 May 25;698:120-128
pubmed: 30849534
N Engl J Med. 1971 Nov 18;285(21):1182-6
pubmed: 4938153

Auteurs

Andrés Valdivia (A)

Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.

Gabriel Mingo (G)

Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.

Varina Aldana (V)

Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.

Mauricio P Pinto (MP)

Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Marco Ramirez (M)

Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Claudio Retamal (C)

Faculty of Medicine and Science, Center of Cellular Biology and Biomedicine (CEBICEM), Universidad San Sebastian, Santiago, Chile.

Alfonso Gonzalez (A)

Faculty of Medicine and Science, Center of Cellular Biology and Biomedicine (CEBICEM), Universidad San Sebastian, Santiago, Chile.

Francisco Nualart (F)

Faculty of Biological Sciences, Universidad de Concepcion, Concepción, Chile.

Alejandro H Corvalan (AH)

Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Advanced Center for Chronic Diseases (ACCDiS), Santiago, Chile.

Gareth I Owen (GI)

Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.
Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Advanced Center for Chronic Diseases (ACCDiS), Santiago, Chile.
Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.

Classifications MeSH